PCV83 COMPARISON OF TREATMENT ADHERENCE AND PERSISTENCE WITH EDOXABAN VERSUS APIXABAN, DABIGATRAN, RIVAROXABAN, AND VITAMIN K ANTAGONIST IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN GERMANY: A PROPENSITY MATCHED COHORT STUDY.

The objective of the study was to compare treatment adherence and persistence to edoxaban with other non-vitamin K antagonist oral anticoagulants (NOAC) - apixaban, dabigatran, rivaroxaban, and vitamin K antagonists (VKA) - in non-valvular atrial fibrillation (NVAF) patients in Germany. Adherence and persistence should be considered in treatment selection to improve patient care. [Extracted from the article]